AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27240397 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular cocoa consumption
Number of subjects: 33
Study 25092937 — intervention group
Group type: EXPERIMENTAL
Intervention: In situ simulation training (4-hour session for multidisciplinary groups of 6 professionals)
Number of subjects: 120
Study 22687173 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intention (if-then plan)
Number of subjects: 0
Study 22687173 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intention (focused on odds of winning)
Number of subjects: 0
Study 22687173 — intervention group
Group type: COMPARATOR
Intervention: Control group (no implementation intention)
Number of subjects: 0
Study 19627686 — intervention group
Group type: EXPERIMENTAL
Intervention: New therapies
Number of subjects: 0
Study 19627686 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised clinical trials
Number of subjects: 0
Study 16904451 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate volume estimated by DRE
Number of subjects: 35323
Study 16904451 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 35323
Study 16904451 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate volume increase (10 cm3)
Number of subjects: 35323
Study 16904451 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of log PSA and prostate volume
Number of subjects: 35323
Study 16904451 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate volume
Number of subjects: 35323
Study 15534554 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide cuff
Number of subjects: 40
Study 15534554 — intervention group
Group type: COMPARATOR
Intervention: Standard cuff
Number of subjects: 40
Study 15534554 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 15534554 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated limb occlusion pressure technique and wide contoured cuff
Number of subjects: 40
Study 11730651 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg
Number of subjects: 15
Study 11730651 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 9386141 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxepa 5 capsules BID for 3 months
Number of subjects: 16
Study 9386141 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 16
Study 7910181 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body disinfection
Number of subjects: 3466
Study 7910181 — intervention group
Group type: EXPERIMENTAL
Intervention: Careful post-discharge follow-up
Number of subjects: 3466
Study 7910181 — intervention group
Group type: COMPARATOR
Intervention: Clean operations
Number of subjects: 3466
Study 7910181 — intervention group
Group type: COMPARATOR
Intervention: Potentially contaminated procedures
Number of subjects: 3466
Study 7910181 — intervention group
Group type: COMPARATOR
Intervention: Horizontal wounds
Number of subjects: 3466
Study 7910181 — intervention group
Group type: COMPARATOR
Intervention: Vertical wounds
Number of subjects: 3466
Study 7910181 — intervention group
Group type: COMPARATOR
Intervention: Use of drains
Number of subjects: 3466
Study 3219274 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone 5 mg bd
Number of subjects: 220
Study 3219274 — intervention group
Group type: COMPARATOR
Intervention: Primary endocrine treatment alone (PET)
Number of subjects: 220
Study 30772906 — intervention group
Group type: EXPERIMENTAL
Intervention: Fidaxomicin
Number of subjects: 0
Study 30772906 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28259552 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning and Coping Strategies (LC) plus Cardiac Rehabilitation (CR)
Number of subjects: 825
Study 28259552 — intervention group
Group type: COMPARATOR
Intervention: Cardiac Rehabilitation (CR) alone
Number of subjects: 825
Study 26666321 — intervention group
Group type: EXPERIMENTAL
Intervention: Information booklet plus one additional pre-operative physiotherapy education and training session
Number of subjects: 441
Study 26666321 — intervention group
Group type: COMPARATOR
Intervention: Information booklet
Number of subjects: 441
Study 23234810 — intervention group
Group type: EXPERIMENTAL
Intervention: Glatiramer acetate 20 mg/d (early-treatment)
Number of subjects: 409
Study 23234810 — intervention group
Group type: COMPARATOR
Intervention: Placebo (delayed-treatment)
Number of subjects: 409
Study 21218293 — intervention group
Group type: EXPERIMENTAL
Intervention: Negatively framed education about CPAP
Number of subjects: 70
Study 21218293 — intervention group
Group type: COMPARATOR
Intervention: Positively framed education about CPAP
Number of subjects: 70
Study 18419877 — intervention group
Group type: EXPERIMENTAL
Intervention: budesonide DPI‐A 200 microg x 4 inhalations
Number of subjects: 37
Study 18419877 — intervention group
Group type: EXPERIMENTAL
Intervention: budesonide DPI‐B 180 microg x 4 inhalations
Number of subjects: 37
Study 18419877 — intervention group
Group type: EXPERIMENTAL
Intervention: budesonide DPI‐B 90 microg x 8 inhalations
Number of subjects: 37
Study 15333721 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-enriched baby food (115 mg DHA/100 g food, 1 jar (113 g)/d)
Number of subjects: 51
Study 15333721 — intervention group
Group type: COMPARATOR
Intervention: Control baby food (0 mg DHA)
Number of subjects: 51
Study 15333721 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-enriched baby food
Number of subjects: 51
Study 15333721 — intervention group
Group type: COMPARATOR
Intervention: Control baby food
Number of subjects: 51
Study 12236335 — intervention group
Group type: EXPERIMENTAL
Intervention: Monetary incentive
Number of subjects: 43
Study 12236335 — intervention group
Group type: COMPARATOR
Intervention: No monetary incentive (control)
Number of subjects: 43
Study 11907915 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy diet
Number of subjects: 100
Study 11907915 — intervention group
Group type: EXPERIMENTAL
Intervention: Linseed diet
Number of subjects: 100
Study 11907915 — intervention group
Group type: COMPARATOR
Intervention: Wheat diet
Number of subjects: 100
Study 8083711 — intervention group
Group type: EXPERIMENTAL
Intervention: Split hyperfractionated radiotherapy (2.0 Gy/d for 30 to 40 days, total 48 Gy to 60 Gy) and chemotherapy (cisplatin 80 to 100 mg/m2 and fluorouracil 1,000 mg/m2 for 3 to 4 days, +/- vindesine 8 mg/m2 for two cycles)
Number of subjects: 91
Study 8083711 — intervention group
Group type: EXPERIMENTAL
Intervention: Split hyperfractionated radiotherapy and chemotherapy
Number of subjects: 91
Study 2809258 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified acellular pertussis vaccine (12.5 micrograms LPF and 12.5 micrograms FHA)
Number of subjects: 130
Study 2809258 — intervention group
Group type: COMPARATOR
Intervention: Conventional pertussis vaccine
Number of subjects: 130
Study 1108565 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin 5,000 i.u. every 12 hours
Number of subjects: 100
Study 1108565 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 31799870 — intervention group
Group type: EXPERIMENTAL
Intervention: Histogram-based features
Number of subjects: 115
Study 31799870 — intervention group
Group type: EXPERIMENTAL
Intervention: Histogram-based features and texture-based features
Number of subjects: 115
Study 31799870 — intervention group
Group type: EXPERIMENTAL
Intervention: Histogram-based features and Laws features
Number of subjects: 115
Study 31799870 — intervention group
Group type: EXPERIMENTAL
Intervention: Histogram-based features, texture-based features, and Laws features
Number of subjects: 115
Study 31661012 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological dressing composed of fetal fibroblasts and keratinocytes
Number of subjects: 0
Study 31661012 — intervention group
Group type: COMPARATOR
Intervention: Traditional dressing
Number of subjects: 0
Study 27610591 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 29
Study 27610591 — intervention group
Group type: COMPARATOR
Intervention: Health Education
Number of subjects: 29
Study 25982826 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain Fitness
Number of subjects: 27
Study 25982826 — intervention group
Group type: COMPARATOR
Intervention: Health education
Number of subjects: 27
Study 24206740 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (Lactobacillus acidophilus)
Number of subjects: 90
Study 24206740 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose
Number of subjects: 90
Study 24206740 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 22123381 — intervention group
Group type: EXPERIMENTAL
Intervention: Levocetirizine, 5 mg daily for 1 week
Number of subjects: 30
Study 22123381 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine, 10 mg daily for 1 week
Number of subjects: 30
Study 22123381 — intervention group
Group type: COMPARATOR
Intervention: Placebo pill for 1 week
Number of subjects: 30
Study 19329820 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG with surgical ventricular reconstruction
Number of subjects: 1000
Study 19329820 — intervention group
Group type: COMPARATOR
Intervention: CABG alone
Number of subjects: 1000
Study 16691131 — intervention group
Group type: EXPERIMENTAL
Intervention: ICP-directed therapy in patients with severe TBI (n = 24)
Number of subjects: 27
Study 16691131 — intervention group
Group type: EXPERIMENTAL
Intervention: PILOT scale scores for severe TBI patients (group 1)
Number of subjects: 27
Study 16691131 — intervention group
Group type: COMPARATOR
Intervention: PILOT scale scores for mild-moderate TBI patients (group 2)
Number of subjects: 27
Study 16691131 — intervention group
Group type: COMPARATOR
Intervention: PILOT scale scores for extracranial trauma patients (group 3)
Number of subjects: 27
Study 16691131 — intervention group
Group type: COMPARATOR
Intervention: PILOT scale scores for nontraumatic illness patients (group 4)
Number of subjects: 27
Study 16691131 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of PILOT scale scores with Glasgow Coma Scale
Number of subjects: 27
Study 16691131 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of PILOT scale scores with overall Injury Severity Score
Number of subjects: 27
Study 16691131 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of PILOT scale scores with head component of Injury Severity Score
Number of subjects: 27
Study 16691131 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of PILOT scale scores with 6-month Glasgow Outcome Scale
Number of subjects: 27
Study 16691131 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of PILOT scale scores with ICP burden
Number of subjects: 27
Study 16691131 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of PILOT scale scores with mean ICP
Number of subjects: 27
Study 15285121 — intervention group
Group type: EXPERIMENTAL
Intervention: Different descriptions of winning conditions (e.g., 'if one or the other but not both picks a red card' vs. 'if one or the other but not both picks a black card')
Number of subjects: 0
Study 11399700 — intervention group
Group type: EXPERIMENTAL
Intervention: OM-85 BV
Number of subjects: 54
Study 11399700 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 9421821 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated pursed lips breathing (SPLB) with positive expiratory pressure of 5 cm H2O
Number of subjects: 12
Study 9421821 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated pursed lips breathing (SPLB)
Number of subjects: 12
Study 8276048 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 1.25 mg
Number of subjects: 48
Study 8276048 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 2.5 mg
Number of subjects: 48
Study 8276048 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 5 mg
Number of subjects: 48
Study 8276048 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 3440636 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin 20 mg
Number of subjects: 20
Study 3440636 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide 25 mg
Number of subjects: 20
Study 3440636 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ketanserin and hydrochlorothiazide
Number of subjects: 20
Study 30355094 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular thrombectomy (EVT)
Number of subjects: 214
Study 30355094 — intervention group
Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 214
Study 29444393 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% inspired sevoflurane in 50% O₂/N₂0, no manually assisted ventilation
Number of subjects: 20
Study 29444393 — intervention group
Group type: COMPARATOR
Intervention: 8% inspired sevoflurane in 50% O₂/N₂0, manually supported ventilation upon loss of consciousness
Number of subjects: 20
Study 25064437 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginterferon lambda-1a (Lambda) 120/180/240 μg
Number of subjects: 392
Study 25064437 — intervention group
Group type: COMPARATOR
Intervention: Peginterferon alfa-2a (alfa) 180 μg
Number of subjects: 392
Study 25064437 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginterferon lambda-1a (Lambda) 180 μg
Number of subjects: 392
Study 25064437 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginterferon lambda-1a (Lambda) 240 μg
Number of subjects: 392
Study 25064437 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginterferon lambda-1a (Lambda)
Number of subjects: 392
Study 25064437 — intervention group
Group type: COMPARATOR
Intervention: Peginterferon alfa-2a (alfa)
Number of subjects: 392
Study 22778122 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation (n = 51)
Number of subjects: 154
Study 22778122 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (n = 47)
Number of subjects: 154
Study 22778122 — intervention group
Group type: COMPARATOR
Intervention: Control (n = 51)
Number of subjects: 154
Study 22778122 — intervention group
Group type: COMPARATOR
Intervention: Comparison of meditation vs control
Number of subjects: 154
Study 22778122 — intervention group
Group type: COMPARATOR
Intervention: Comparison of exercise vs control
Number of subjects: 154
Study 20472939 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP treatment
Number of subjects: 1316
Study 20472939 — intervention group
Group type: COMPARATOR
Intervention: Surfactant treatment
Number of subjects: 1316
Study 18762591 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-focused treatment for adolescents (FFT-A) and protocol pharmacotherapy (n = 30)
Number of subjects: 58
Study 18762591 — intervention group
Group type: COMPARATOR
Intervention: Enhanced care (EC) and protocol pharmacotherapy (n = 28)
Number of subjects: 58
Study 16856132 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTA) immediately reconstituted with saline
Number of subjects: 32
Study 16856132 — intervention group
Group type: COMPARATOR
Intervention: Botulinum toxin A (BTA) stored in refrigerator for 1 week or more
Number of subjects: 32
Study 12047055 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning items by rote
Number of subjects: 78
Study 12047055 — intervention group
Group type: EXPERIMENTAL
Intervention: Performing a short‐term matching task
Number of subjects: 78
Study 12047055 — intervention group
Group type: EXPERIMENTAL
Intervention: Searching for the rules of the grammar
Number of subjects: 78
Study 10418657 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical interventions including advice to re-engage in activity, support to develop personalized goals, reinforcement for healthy gains and appropriate functional activities, and physical conditioning exercises.
Number of subjects: 16
Study 10418657 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions promoting communication at the work-site or modifying the patient's job.
Number of subjects: 16
Study 7887641 — intervention group
Group type: EXPERIMENTAL
Intervention: TAP-144-SR 3.75mg
Number of subjects: 95
Study 7887641 — intervention group
Group type: EXPERIMENTAL
Intervention: TAP-144-SR 7.5mg
Number of subjects: 95
Study 19256131 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 335000 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-virus vaccine
Number of subjects: 0
Study 335000 — intervention group
Group type: COMPARATOR
Intervention: Split-product vaccine
Number of subjects: 0
Study 31518717 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Sphincter Augmentation (MSA)
Number of subjects: 152
Study 31518717 — intervention group
Group type: COMPARATOR
Intervention: Proton Pump Inhibitors (PPIs)
Number of subjects: 152
Study 31263057 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (81 mg/day)
Number of subjects: 1121
Study 31263057 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose aspirin (325 mg/day)
Number of subjects: 1121
Study 31263057 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 1121
Study 28713729 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezotome (Piezosurgery)
Number of subjects: 30
Study 28713729 — intervention group
Group type: COMPARATOR
Intervention: Conventional rotatory osteotomy
Number of subjects: 30
Study 25833022 — intervention group
Group type: EXPERIMENTAL
Intervention: Idazoxan (40 mg)
Number of subjects: 10
Study 25833022 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 23369221 — intervention group
Group type: EXPERIMENTAL
Intervention: Volumetric Modulated Arc Therapy (VMAT)
Number of subjects: 5
Study 23369221 — intervention group
Group type: COMPARATOR
Intervention: Intensity-Modulated Radiation Therapy (IMRT)
Number of subjects: 5
Study 21610123 — intervention group
Group type: EXPERIMENTAL
Intervention: diacerein (50 mg once daily for the first 15 days and twice daily for 45 additional days)
Number of subjects: 40
Study 21610123 — intervention group
Group type: EXPERIMENTAL
Intervention: diacerein
Number of subjects: 40
Study 21610123 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study 19492999 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of green tea
Number of subjects: 0
Study 19492999 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of white tea
Number of subjects: 0
Study 19492999 — intervention group
Group type: COMPARATOR
Intervention: Control (no tea application)
Number of subjects: 0
Study 16541308 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB) using a combination of radiopharmaceutical 99mTc‐albumin colloid and Patent Blue V dye
Number of subjects: 842
Study 16541308 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB) using blue dye
Number of subjects: 842
Study 16541308 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB) using isotope
Number of subjects: 842
Study 16541308 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB) using a combination of blue dye and isotope
Number of subjects: 842
Study 16541308 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB) in patients with grade 3 tumors
Number of subjects: 842
Study 16541308 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB) in patients with grade 2 tumors
Number of subjects: 842
Study 16541308 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB) with one SLN harvested
Number of subjects: 842
Study 16541308 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB) with multiple SLNs (three or more) removed
Number of subjects: 842
Study 16541308 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB)
Number of subjects: 842
Study 15155044 — intervention group
Group type: EXPERIMENTAL
Intervention: D.A.R.E. Plus multicomponent intervention
Number of subjects: 24
Study 15155044 — intervention group
Group type: EXPERIMENTAL
Intervention: D.A.R.E. middle school curriculum
Number of subjects: 24
Study 15155044 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 12243706 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin gel microsphere 0.1%
Number of subjects: 0
Study 12243706 — intervention group
Group type: COMPARATOR
Intervention: Adapalene gel 0.1%
Number of subjects: 0
Study 10984871 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedside wellness system (BSW) intervention
Number of subjects: 0
Study 10984871 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 8858320 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatic dilation
Number of subjects: 29
Study 8858320 — intervention group
Group type: COMPARATOR
Intervention: Botulinum toxin injection
Number of subjects: 29
Study 1644335 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-aminosalicylic acid (4-ASA) 2 g enemas
Number of subjects: 45
Study 1644335 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone 20 mg enemas
Number of subjects: 45
Study 6092557 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment (40 patients)
Number of subjects: 100
Study 6092557 — intervention group
Group type: COMPARATOR
Intervention: Control group (60 patients without lithium)
Number of subjects: 100
Study 6092557 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment with bronchodilators
Number of subjects: 100
Study 6092557 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment (with or without bronchodilators)
Number of subjects: 100
Study 29288501 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine supplementation (10 grams of iodized salt daily)
Number of subjects: 405
Study 29288501 — intervention group
Group type: COMPARATOR
Intervention: Iodine restriction (noniodized salt with low-iodine or noniodine diet)
Number of subjects: 405
Study 26281955 — intervention group
Group type: EXPERIMENTAL
Intervention: Errorless goal management training
Number of subjects: 60
Study 26281955 — intervention group
Group type: COMPARATOR
Intervention: Conventional goal management training
Number of subjects: 60
Study 26281955 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 60
Study 24385534 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferasirox (target dose 40 mg/kg per day)
Number of subjects: 197
Study 24385534 — intervention group
Group type: COMPARATOR
Intervention: Deferoxamine (50‐60 mg/kg per day for 5‐7 days/week)
Number of subjects: 197
Study 24385534 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 197
Study 24385534 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferasirox
Number of subjects: 197